Oil Palm Empty Fruit Bunches as Raw Material of Dissolving Pulp for Viscose Rayon Fiber in Making Textile Products.

The creative fashion industry produces several textile products that play an important role in the national economy. In various countries, this industry has continued to grow along with the strong flow of information technology and e-commerce. The development of textile products for fashion is very dynamic and competitive. Competition is not only about price, but also the quality of organic/synthetic materials, the comfort provided, and designs that change every 4−6 months. Recently, creative fashion not only relies on natural and synthetic polymer-made fibers but also biomass-based waste materials. Therefore, this study aims to manufacture textile products from biomass-based waste materials that can be applied to the creative fashion industry. Two types of raw materials from oil palm empty fruit bunches (EFB), namely, whole-empty fruit bunches (WEFB) and stalk-empty fruit bunches (SEFB), are used as an excellent innovation of rayon viscose fiber (RVF), a noncotton organic yarn capable of providing a solution to the 99% import of global cotton needs. This is expected to increase competitiveness, as well as the added value of palm oil products and their derivatives. The process of manufacturing DP chemically includes prehydrolysis, cooking, bleaching to dissolve the lignin and noncellulosic materials as well as isolation to purify POEFB fiber. Furthermore, DP testing is carried out to determine product quality and compare it with the national product standards. The results show that the alpha-cellulose content reaches >94% with variations in the active alkali of 18%, 20% and 24%. This implies that the WEFB and SEFB are used to fulfill the first requirements of the national standard (SNI 938:2017). The WEFB with an active alkali variation of 24% meets the SNI standard for rayon pulp with a value of S10 = 3.07 and S18 = 7.14%, while all variations of SEFB show opposite results. The use of active alkali at 24% had a brighter color than between 18% and 20%. Additionally, the fiber density of WEFB appears to be higher than that of SEFB. These results correlate positively with DP prepared using 24% alkali as the optimum treatment for all products, as well as the morphological observations performed with scanning electron microscopy (SEM), which shows that WEFB fixated fiber had a larger diameter than SEFB.

Repurposed Antiviral Drugs for Covid-19 - Interim WHO Solidarity Trial Results.

BACKGROUND: World Health Organization expert groups recommended mortality trials of four repurposed antiviral drugs - remdesivir, hydroxychloroquine, lopinavir, and interferon beta-1a - in patients hospitalized with coronavirus disease 2019 (Covid-19). METHODS: We randomly assigned inpatients with Covid-19 equally between one of the trial drug regimens that was locally available and open control (up to five options, four active and the local standard of care). The intention-to-treat primary analyses examined in-hospital mortality in the four pairwise comparisons of each trial drug and its control (drug available but patient assigned to the same care without that drug). Rate ratios for death were calculated with stratification according to age and status regarding mechanical ventilation at trial entry. RESULTS: At 405 hospitals in 30 countries, 11,330 adults underwent randomization; 2750 were assigned to receive remdesivir, 954 to hydroxychloroquine, 1411 to lopinavir (without interferon), 2063 to interferon (including 651 to interferon plus lopinavir), and 4088 to no trial drug. Adherence was 94 to 96% midway through treatment, with 2 to 6% crossover. In total, 1253 deaths were reported (median day of death, day 8; interquartile range, 4 to 14). The Kaplan-Meier 28-day mortality was 11.8% (39.0% if the patient was already receiving ventilation at randomization and 9.5% otherwise). Death occurred in 301 of 2743 patients receiving remdesivir and in 303 of 2708 receiving its control (rate ratio, 0.95; 95% confidence interval [CI], 0.81 to 1.11; P = 0.50), in 104 of 947 patients receiving hydroxychloroquine and in 84 of 906 receiving its control (rate ratio, 1.19; 95% CI, 0.89 to 1.59; P = 0.23), in 148 of 1399 patients receiving lopinavir and in 146 of 1372 receiving its control (rate ratio, 1.00; 95% CI, 0.79 to 1.25; P = 0.97), and in 243 of 2050 patients receiving interferon and in 216 of 2050 receiving its control (rate ratio, 1.16; 95% CI, 0.96 to 1.39; P = 0.11). No drug definitely reduced mortality, overall or in any subgroup, or reduced initiation of ventilation or hospitalization duration. CONCLUSIONS: These remdesivir, hydroxychloroquine, lopinavir, and interferon regimens had little or no effect on hospitalized patients with Covid-19, as indicated by overall mortality, initiation of ventilation, and duration of hospital stay. (Funded by the World Health Organization; ISRCTN Registry number, ISRCTN83971151; ClinicalTrials.gov number, NCT04315948.).

Evaluation of the Performance of Helmet Prototypes Fabricated from Acrylonitrile Butadiene Styrene Composites Filled with Natural Resource.

The performance of helmet prototypes fabricated from acrylonitrile butadiene styrene composites filled with oil palm empty fruit bunch fibers was evaluated. The fibers were produced using a milling procedure, while the composites were fabricated using a single-screw extrusion. The physical characteristics of the produced fibers, which are water content, size, and density, were investigated. In addition, the mechanical properties of the produced helmets, including shock absorption, yield stress, frequency, and head injury criterion (HIC), were examined. The impact strength of the produced helmets increases with the rise of filler content. In addition, the helmets were also able to withstand a considerable pressure such that the transmitted pressure was far under the maximum value acceptable by the human skull. The present work also found that HICs exhibited by the investigated helmet prototypes fulfill all the practical guidelines as permitted by the Indonesian government. In terms of novelty, such innovation can be considered the first invention in Indonesia since the endorsement of the use of motorcycle helmets.